Stock comparison

BIIBvsGILD

Biogen IncvsGilead Sciences Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BIIB

Biogen Inc

$184.38

+7.51%

Biotechnology$25.8BNASDAQ

GILD

Gilead Sciences Inc

$130.4

+7.35%

Biotechnology$173.4BNASDAQ

60-day price, rebased to 100

BIIB +2.50% · GILD -8.99%

Round-by-round

BIIB 2·GILD 4

EdgeBIIB

Valuation upside

+9.40% vs -25.70% to DCF fair value

EdgeGILD

Balance-sheet strength

Altman Z 3.10 vs 4.47

EdgeGILD

Fundamental quality

Piotroski 6.00 vs 8.00 (of 9)

EdgeGILD

Growth + margins

Rule-of-40 23.00 vs 34.50

EdgeBIIB

60-day momentum

+2.50% vs -8.99% price return

EdgeGILD

Market-cap liquidity

$25.8B vs $173.4B

Verdict

Across6categories,GILDtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBIIBorGILD

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.